Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1155338

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1155338

Europe Cellular Health Screening Market Size, Share & Industry Trends Analysis Report By Sample Type, By Collection Site, By Test Type, By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 85 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The Europe Cellular Health Screening Market would witness market growth of 8.7% CAGR during the forecast period (2022-2028).

Compound library screening for effects on living cells has evolved over the past ten years into a crucial and essential phase in almost every drug discovery effort. This strategy emerged from the awareness that biochemical assay-based screening campaigns, while incredibly productive, had fallen short of their promise to produce safer and more effective medications. The obvious benefit of screening utilizing cell-based assays is the ability to assess a compound's effects against molecular targets while it is still in a living cell.

However, screening also permits broad, systems biology techniques to study cellular pathways implicated in disease processes. In fact, cell-based diagnostic technologies have made it possible for researchers studying drug discovery to create models of interlinked cellular pathways, gather crucial data for particular disease models, and create companion diagnostics based on pertinent cellular biomarkers for treatments.

Cell-based screening automated systems are developing. The potential to screen substances against druggable targets in the regard of living cells has essentially become standard practice in both secondary and primary drug-screening programs, ranging from straightforward cell-based fluorescent, luminescent, colorimetric, and radiologic plate reader assays to real-time intracellular calcium feedback measurement techniques and high-content fluorescent imaging systems.

The EU recently introduced a novel strategy to assist Member States in boosting cancer screening uptake as a component of the EU Cancer Screening Scheme to be proposed under Europe's Beating Cancer Plan. The goal of the new guideline is to increase screenings, covering additional target groups and malignancies, with a focus on early cancer diagnosis. According to the European Commission, by 2025, 90% of EU citizens who are eligible for breast, cervical, and colorectal cancer examinations will be provided with such screenings owing to a new EU strategy that is based on the most recent scientific advancements and data. The revised guideline also includes lung, prostate, and, in some cases, stomach cancers in population-based organized cancer screening.

The Germany market dominated the Europe Cellular Health Screening Market by Country in 2021; thereby, achieving a market value of $278.2 million by 2028. The UK market would witness a CAGR of 7.8% during (2022 - 2028). Additionally, The France market is anticipated to grow a CAGR of 9.6% during (2022 - 2028).

Based on Sample Type, the market is segmented into Blood, Saliva, Serum, and Urine. Based on Collection Site, the market is segmented into Hospital, Diagnostic Labs, Home, and Office. Based on Test Type, the market is segmented into Single Test Panels and Multi-test Panels. Based on Single Test Panels Type, the market is segmented into Oxidative Stress Tests, Inflammation Tests, Telomere Tests, and Heavy Metals Tests. The report also covers geographical segmentation of Cellular Health Screening market. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics Incorporated, OPKO Health, Inc., Laboratory Corporation of America Holdings, Genova Diagnostics, Telomere Diagnostics, Inc., Life Length, S.L., Repeat Diagnostics, Inc., SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.), Cell Science Systems Corp. and Segterra, Inc.

Scope of the Study

Market Segments covered in the Report:

By Sample Type

  • Blood
  • Saliva
  • Serum
  • Urine

By Collection Site

  • Hospital
  • Diagnostic Labs
  • Home
  • Office

By Test Type

  • Single Test Panels
    • Oxidative Stress Tests
    • Inflammation Tests
    • Telomere Tests
    • Heavy Metals Tests
  • Multi-test Panels

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Companies Profiled

  • Quest Diagnostics Incorporated
  • OPKO Health, Inc.
  • Laboratory Corporation of America Holdings
  • Genova Diagnostics
  • Telomere Diagnostics, Inc.
  • Life Length, S.L.
  • Repeat Diagnostics, Inc.
  • SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.)
  • Cell Science Systems Corp.
  • Segterra, Inc.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 Europe Cellular Health Screening Market, by Sample Type
    • 1.4.2 Europe Cellular Health Screening Market, by Collection Site
    • 1.4.3 Europe Cellular Health Screening Market, by Test Type
    • 1.4.4 Europe Cellular Health Screening Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition and Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Europe Cellular Health Screening Market by Sample Type

  • 3.1 Europe Blood Market by Country
  • 3.2 Europe Saliva Market by Country
  • 3.3 Europe Serum Market by Country
  • 3.4 Europe Urine Market by Country

Chapter 4. Europe Cellular Health Screening Market by Collection Site

  • 4.1 Europe Hospital Market by Country
  • 4.2 Europe Diagnostic Labs Market by Country
  • 4.3 Europe Home Market by Country
  • 4.4 Europe Office Market by Country

Chapter 5. Europe Cellular Health Screening Market by Test Type

  • 5.1 Europe Single Test Panels Market by Country
  • 5.2 Europe Cellular Health Screening Market by Single Test Panels Type
    • 5.2.1 Europe Oxidative Stress Tests Market by Country
    • 5.2.2 Europe Inflammation Tests Market by Country
    • 5.2.3 Europe Telomere Tests Market by Country
    • 5.2.4 Europe Heavy Metals Tests Market by Country
  • 5.3 Europe Multi-test Panels Market by Country

Chapter 6. Europe Cellular Health Screening Market by Country

  • 6.1 Germany Cellular Health Screening Market
    • 6.1.1 Germany Cellular Health Screening Market by Sample Type
    • 6.1.2 Germany Cellular Health Screening Market by Collection Site
    • 6.1.3 Germany Cellular Health Screening Market by Test Type
      • 6.1.3.1 Germany Cellular Health Screening Market by Single Test Panels Type
  • 6.2 UK Cellular Health Screening Market
    • 6.2.1 UK Cellular Health Screening Market by Sample Type
    • 6.2.2 UK Cellular Health Screening Market by Collection Site
    • 6.2.3 UK Cellular Health Screening Market by Test Type
      • 6.2.3.1 UK Cellular Health Screening Market by Single Test Panels Type
  • 6.3 France Cellular Health Screening Market
    • 6.3.1 France Cellular Health Screening Market by Sample Type
    • 6.3.2 France Cellular Health Screening Market by Collection Site
    • 6.3.3 France Cellular Health Screening Market by Test Type
      • 6.3.3.1 France Cellular Health Screening Market by Single Test Panels Type
  • 6.4 Russia Cellular Health Screening Market
    • 6.4.1 Russia Cellular Health Screening Market by Sample Type
    • 6.4.2 Russia Cellular Health Screening Market by Collection Site
    • 6.4.3 Russia Cellular Health Screening Market by Test Type
      • 6.4.3.1 Russia Cellular Health Screening Market by Single Test Panels Type
  • 6.5 Spain Cellular Health Screening Market
    • 6.5.1 Spain Cellular Health Screening Market by Sample Type
    • 6.5.2 Spain Cellular Health Screening Market by Collection Site
    • 6.5.3 Spain Cellular Health Screening Market by Test Type
      • 6.5.3.1 Spain Cellular Health Screening Market by Single Test Panels Type
  • 6.6 Italy Cellular Health Screening Market
    • 6.6.1 Italy Cellular Health Screening Market by Sample Type
    • 6.6.2 Italy Cellular Health Screening Market by Collection Site
    • 6.6.3 Italy Cellular Health Screening Market by Test Type
      • 6.6.3.1 Italy Cellular Health Screening Market by Single Test Panels Type
  • 6.7 Rest of Europe Cellular Health Screening Market
    • 6.7.1 Rest of Europe Cellular Health Screening Market by Sample Type
    • 6.7.2 Rest of Europe Cellular Health Screening Market by Collection Site
    • 6.7.3 Rest of Europe Cellular Health Screening Market by Test Type
      • 6.7.3.1 Rest of Europe Cellular Health Screening Market by Single Test Panels Type

Chapter 7. Company Profiles

  • 7.1 Quest Diagnostics Incorporated
    • 7.1.1 Company Overview
    • 7.1.2 Financial Analysis
    • 7.1.3 Segmental Analysis
    • 7.1.4 Recent strategies and developments:
      • 7.1.4.1 Partnerships, Collaborations, and Agreements:
      • 7.1.4.2 Product Launches and Product Expansions:
  • 7.2 OPKO Health, Inc.
    • 7.2.1 Company Overview
    • 7.2.2 Financial Analysis
    • 7.2.3 Segmental and Regional Analysis
    • 7.2.4 Research & Development Expenses
  • 7.3 Laboratory Corporation of America Holdings
    • 7.3.1 Company Overview
    • 7.3.2 Financial Analysis
    • 7.3.3 Segmental Analysis
  • 7.4 Genova Diagnostics
    • 7.4.1 Company Overview
    • 7.4.2 Recent strategies and developments:
      • 7.4.2.1 Partnerships, Collaborations, and Agreements:
  • 7.5 Telomere Diagnostics, Inc.
    • 7.5.1 Company Overview
  • 7.6 Life Length, S.L.
    • 7.6.1 Company Overview
  • 7.7 Repeat Diagnostics, Inc.
    • 7.7.1 Company Overview
  • 7.8 SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.)
    • 7.8.1 Company Overview
  • 7.9 Cell Science Systems Corp.
    • 7.9.1 Company Overview
  • 7.10. Segterra, Inc. (INSIDETRACKER)
    • 7.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 Europe Cellular Health Screening Market, 2018 - 2021, USD Million
  • TABLE 2 Europe Cellular Health Screening Market, 2022 - 2028, USD Million
  • TABLE 3 Europe Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 4 Europe Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 5 Europe Blood Market by Country, 2018 - 2021, USD Million
  • TABLE 6 Europe Blood Market by Country, 2022 - 2028, USD Million
  • TABLE 7 Europe Saliva Market by Country, 2018 - 2021, USD Million
  • TABLE 8 Europe Saliva Market by Country, 2022 - 2028, USD Million
  • TABLE 9 Europe Serum Market by Country, 2018 - 2021, USD Million
  • TABLE 10 Europe Serum Market by Country, 2022 - 2028, USD Million
  • TABLE 11 Europe Urine Market by Country, 2018 - 2021, USD Million
  • TABLE 12 Europe Urine Market by Country, 2022 - 2028, USD Million
  • TABLE 13 Europe Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
  • TABLE 14 Europe Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
  • TABLE 15 Europe Hospital Market by Country, 2018 - 2021, USD Million
  • TABLE 16 Europe Hospital Market by Country, 2022 - 2028, USD Million
  • TABLE 17 Europe Diagnostic Labs Market by Country, 2018 - 2021, USD Million
  • TABLE 18 Europe Diagnostic Labs Market by Country, 2022 - 2028, USD Million
  • TABLE 19 Europe Home Market by Country, 2018 - 2021, USD Million
  • TABLE 20 Europe Home Market by Country, 2022 - 2028, USD Million
  • TABLE 21 Europe Office Market by Country, 2018 - 2021, USD Million
  • TABLE 22 Europe Office Market by Country, 2022 - 2028, USD Million
  • TABLE 23 Europe Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
  • TABLE 24 Europe Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
  • TABLE 25 Europe Single Test Panels Market by Country, 2018 - 2021, USD Million
  • TABLE 26 Europe Single Test Panels Market by Country, 2022 - 2028, USD Million
  • TABLE 27 Europe Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
  • TABLE 28 Europe Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
  • TABLE 29 Europe Oxidative Stress Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 30 Europe Oxidative Stress Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 31 Europe Inflammation Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 32 Europe Inflammation Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 33 Europe Telomere Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 34 Europe Telomere Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 35 Europe Heavy Metals Tests Market by Country, 2018 - 2021, USD Million
  • TABLE 36 Europe Heavy Metals Tests Market by Country, 2022 - 2028, USD Million
  • TABLE 37 Europe Multi-test Panels Market by Country, 2018 - 2021, USD Million
  • TABLE 38 Europe Multi-test Panels Market by Country, 2022 - 2028, USD Million
  • TABLE 39 Europe Cellular Health Screening Market by Country, 2018 - 2021, USD Million
  • TABLE 40 Europe Cellular Health Screening Market by Country, 2022 - 2028, USD Million
  • TABLE 41 Germany Cellular Health Screening Market, 2018 - 2021, USD Million
  • TABLE 42 Germany Cellular Health Screening Market, 2022 - 2028, USD Million
  • TABLE 43 Germany Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 44 Germany Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 45 Germany Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
  • TABLE 46 Germany Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
  • TABLE 47 Germany Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
  • TABLE 48 Germany Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
  • TABLE 49 Germany Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
  • TABLE 50 Germany Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
  • TABLE 51 UK Cellular Health Screening Market, 2018 - 2021, USD Million
  • TABLE 52 UK Cellular Health Screening Market, 2022 - 2028, USD Million
  • TABLE 53 UK Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 54 UK Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 55 UK Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
  • TABLE 56 UK Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
  • TABLE 57 UK Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
  • TABLE 58 UK Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
  • TABLE 59 UK Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
  • TABLE 60 UK Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
  • TABLE 61 France Cellular Health Screening Market, 2018 - 2021, USD Million
  • TABLE 62 France Cellular Health Screening Market, 2022 - 2028, USD Million
  • TABLE 63 France Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 64 France Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 65 France Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
  • TABLE 66 France Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
  • TABLE 67 France Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
  • TABLE 68 France Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
  • TABLE 69 France Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
  • TABLE 70 France Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
  • TABLE 71 Russia Cellular Health Screening Market, 2018 - 2021, USD Million
  • TABLE 72 Russia Cellular Health Screening Market, 2022 - 2028, USD Million
  • TABLE 73 Russia Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 74 Russia Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 75 Russia Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
  • TABLE 76 Russia Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
  • TABLE 77 Russia Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
  • TABLE 78 Russia Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
  • TABLE 79 Russia Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
  • TABLE 80 Russia Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
  • TABLE 81 Spain Cellular Health Screening Market, 2018 - 2021, USD Million
  • TABLE 82 Spain Cellular Health Screening Market, 2022 - 2028, USD Million
  • TABLE 83 Spain Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 84 Spain Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 85 Spain Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
  • TABLE 86 Spain Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
  • TABLE 87 Spain Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
  • TABLE 88 Spain Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
  • TABLE 89 Spain Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
  • TABLE 90 Spain Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
  • TABLE 91 Italy Cellular Health Screening Market, 2018 - 2021, USD Million
  • TABLE 92 Italy Cellular Health Screening Market, 2022 - 2028, USD Million
  • TABLE 93 Italy Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 94 Italy Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 95 Italy Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
  • TABLE 96 Italy Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
  • TABLE 97 Italy Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
  • TABLE 98 Italy Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
  • TABLE 99 Italy Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
  • TABLE 100 Italy Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
  • TABLE 101 Rest of Europe Cellular Health Screening Market, 2018 - 2021, USD Million
  • TABLE 102 Rest of Europe Cellular Health Screening Market, 2022 - 2028, USD Million
  • TABLE 103 Rest of Europe Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
  • TABLE 104 Rest of Europe Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
  • TABLE 105 Rest of Europe Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
  • TABLE 106 Rest of Europe Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
  • TABLE 107 Rest of Europe Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
  • TABLE 108 Rest of Europe Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
  • TABLE 109 Rest of Europe Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
  • TABLE 110 Rest of Europe Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
  • TABLE 111 Key information - Quest Diagnostics Incorporated
  • TABLE 112 Key Information - OPKO Health, Inc.
  • TABLE 113 Key Information - Laboratory Corporation of America holdings
  • TABLE 114 Key Information - Genova Diagnostics
  • TABLE 115 Key Information - Telomere Diagnostics, Inc.
  • TABLE 116 Key Information - LIFE LENGTH, S.L.
  • TABLE 117 Key Information - Repeat Diagnostics, Inc.
  • TABLE 118 Key Information - SpectraCell Laboratories, Inc.
  • TABLE 119 Key Information - Cell Science Systems Corp.
  • TABLE 120 Key Information - SEGTERRA (INSIDETRACKER)

List of Figures

  • FIG 1 Methodology for the research
  • FIG 2 Recent strategies and developments: Quest Diagnostics Incorporated
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!